Y-L Chen

MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation

M. Hsiao, S. Yeh, K-H Lee, 2009, Oncogene.

Upregulation of the oncoprotein SET determines poor clinical outcomes in hepatocellular carcinoma and shows therapeutic potential

C. Shiau, M. Hung, P. Chu, 2016, Oncogene.

Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells

J. Chang, Yu-lin Chen, Y. Yen, 2017, Oncogene.

Downregulated miR-328 suppressed cell invasion and growth in hepatocellular carcinoma via targeting PTEN.

L. Li, Y-L Chen, F. Liang, 2018, European review for medical and pharmacological sciences.

Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A

C. Shiau, M. Hung, P. Chu, 2014, Cell Death and Disease.

α-Catulin knockdown induces senescence in cancer cells

T. Hong, W. Chiang, T. Wong, 2011, Oncogene.

Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation

D. Shieh, Szu-Hua Pan, W. Chiang, 2018, Oncogene.

Regulation of DNA methylation and tumor suppression gene expression by miR-29b in leukemia patients and related mechanisms.

Y-L Chen, Li-Hong Shou, Z-X Zhang, 2018, European review for medical and pharmacological sciences.

Evaluation of miR-429 as a novel serum biomarker for pancreatic ductal adenocarcinoma and analysis its tumor suppressor function and target genes.

Y-L Chen, J-Y Wu, J.M. Hong, 2022, European review for medical and pharmacological sciences.